SA Transcripts • Nov. 17, 2008
We currently have no Breaking News on this stock.
There are no StockTalks on this stock yet.
Nanogen's in vitro diagnostic products provide researchers, clinicians and physicians worldwide with improved methods and tools to predict, diagnose, and ultimately help treat disease. The company's products include real-time PCR reagents and a line of rapid, point-of-care diagnostic tests.
Other News & PR